Erythropoietin use in a pregnant Jehovah's Witness with anemia and β-thalassemia: A case report

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 50, Issue 2, 2005, Pages 135-137

  Bennett, Melissa ^a   Macri, Charles J ^a   Bathgate, Susanne L ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Anemia; Beta thalassemia; Jehovah's Witnesses; Recombinant erythropoietin

Indexed keywords

AMPICILLIN; DEXAMETHASONE; ERYTHROPOIETIN; TERBUTALINE;

ADULT; AFRICAN AMERICAN; ANEMIA; ARTICLE; BETA THALASSEMIA; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DYSPNEA; FATIGUE; FEMALE; HUMAN; IRON THERAPY; PRIORITY JOURNAL;

ADULT; ANEMIA, IRON-DEFICIENCY; BETA-THALASSEMIA; ERYTHROPOIETIN; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; JEHOVAH'S WITNESSES; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 13444287963     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Harrison BG: Visions of Glory: A History and Memory of Jehovah's Witnesses. New York, Simon and Shuster, 1978
2. Erythropoietin (Procrit; Epogen) revisited. Med Lett Drugs Ther 2001;43:40-41
3. Erlich L: Use of EPOGEN for treatment of anemia associated with chronic renal failure. Crit Care Nurs Clin North Am 1990;2:101-113
4. Braga J, Marques R, Branco A, et al: Maternal and perinatal implications of the use of human recombinant erythropoietin. Acta Obstet Gynecol Scand 1996;75:449-453
5. Widness JA, Schmidt RL, Sawyer ST: Erythropoietin transplacental passage: Review of animal studies. J Perinat Med 1995;23:61-70
6. Schneider H, Malek A: Lack of permeability of the human placenta for erythropoietin. J Perinat Med 1995;23:71-76
7. The Watchtower: Pittsburgh, Watch Tower Bible and Tract Society of Pennsylvania, 1994, p 31